Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,566 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with "mid-range" QRS duration.
Yamamoto N, Noda T, Nakano M, Ito T, Sato H, Hayashi H, Chiba T, Hasebe Y, Ueda N, Kamakura T, Ishibashi K, Miyata S, Kusano K, Yasuda S. Yamamoto N, et al. Among authors: ito t. Heart Rhythm. 2024 Jun;21(6):855-862. doi: 10.1016/j.hrthm.2024.02.019. Epub 2024 Feb 15. Heart Rhythm. 2024. PMID: 38367890 Free article.
Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial.
Ogura T, Suda T, Inase N, Nishioka Y, Azuma A, Okamoto M, Takizawa A, Ito T, Rohr KB, Inoue Y. Ogura T, et al. Among authors: ito t. Respir Investig. 2022 Nov;60(6):787-797. doi: 10.1016/j.resinv.2022.06.009. Epub 2022 Aug 1. Respir Investig. 2022. PMID: 35927208 Free article. Clinical Trial.
The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial.
Inoue Y, Kitamura H, Okamoto M, Ogura T, Nishioka Y, Kuwana M, Taniguchi A, Ito T, Rohr KB, Suda T. Inoue Y, et al. Among authors: ito t. Respir Investig. 2024 Jul;62(4):589-596. doi: 10.1016/j.resinv.2024.04.008. Epub 2024 Apr 30. Respir Investig. 2024. PMID: 38692040 Free article. Clinical Trial.
Risk Classification of Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin.
Ishikawa G, Matsushita Y, Kitagawa Y, Uchiyama A, Oishi Y, Tanaka H, Watanabe S, Suzuki E, Watanabe S, Watanabe K, Watanabe H, Tamura K, Motoyama D, Matsumoto R, Ito T, Nagata M, Unno T, Furuse H, Mizuno T, Otsuka A. Ishikawa G, et al. Among authors: ito t. Cancer Diagn Progn. 2024 Nov 3;4(6):783-788. doi: 10.21873/cdp.10396. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502620 Free PMC article.
Effects of aging on otolith morphology and functions in mice.
Ueda K, Imai T, Ito T, Okayasu T, Harada S, Kamakura T, Ono K, Katsuno T, Tanaka T, Tatsumi K, Hibino H, Wanaka A, Kitahara T. Ueda K, et al. Among authors: ito t. Front Neurosci. 2024 Oct 16;18:1466514. doi: 10.3389/fnins.2024.1466514. eCollection 2024. Front Neurosci. 2024. PMID: 39479359 Free PMC article.
11,566 results
You have reached the last available page of results. Please see the User Guide for more information.